Inflammatory signaling via TNF, and SPP1-CD44 was also enhanced, suggesting that MM ECs are responsive to pro-angiogenic and pro-inflammatory cues within the microenvironment. This evidence concerns the gene CD44 and Miyoshi myopathy.